These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1600683)
1. New labeling and patient insert for triazolam approved by FDA. Clin Pharm; 1992 Jun; 11(6):467. PubMed ID: 1600683 [No Abstract] [Full Text] [Related]
2. Lost in transmission--FDA drug information that never reaches clinicians. Schwartz LM; Woloshin S N Engl J Med; 2009 Oct; 361(18):1717-20. PubMed ID: 19846841 [No Abstract] [Full Text] [Related]
3. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121 [TBL] [Abstract][Full Text] [Related]
4. Clip & Save Drug Chart: FDA-approved drugs to treat sleep disorders. J Psychosoc Nurs Ment Health Serv; 2010 Oct; 48(10):7-8. PubMed ID: 20954585 [No Abstract] [Full Text] [Related]
5. FDA proposes that patient package insert program be rescinded. Hospitals; 1982 Feb; 56(4):84. PubMed ID: 7054117 [No Abstract] [Full Text] [Related]
6. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule. Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520 [TBL] [Abstract][Full Text] [Related]
7. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule. Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154 [TBL] [Abstract][Full Text] [Related]
8. [Effects of the chronic administration of triazolam 0.50 mg on the sleep of insomniacs]. Stepanski E; Zorick F; Kaffeman M; Sicklesteel J; Roth T Nouv Presse Med; 1982 Oct; 11(40):2987-90. PubMed ID: 6128721 [TBL] [Abstract][Full Text] [Related]
9. Unapproved uses of approved drugs: The physician, the package insert, and the FDA. Pediatrics; 1978 Aug; 62(2):262-4. PubMed ID: 693165 [No Abstract] [Full Text] [Related]
10. Triazolam--a new benzodiazepine for insomnia. Med Lett Drugs Ther; 1983 Mar; 25(631):32. PubMed ID: 6131375 [No Abstract] [Full Text] [Related]
11. The risks of pharmacological therapy for insomnia (part 1): update for the clinical nurse specialist. O'Malley P Clin Nurse Spec; 2007; 21(4):188-90. PubMed ID: 17622806 [No Abstract] [Full Text] [Related]
12. From off-label prescribing towards a new FDA. Tabarrok A Med Hypotheses; 2009 Jan; 72(1):11-3. PubMed ID: 18835103 [TBL] [Abstract][Full Text] [Related]
13. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
14. Sources of drug information: FDA-approved labeling and other official FDA sources. Lindstrom JA Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349 [TBL] [Abstract][Full Text] [Related]
15. The patient package insert--health care provider's friend or foe? Hirsh HL Nurs Homes; 1979; 28(4):24-5. PubMed ID: 10283734 [No Abstract] [Full Text] [Related]
17. New FDA rules force drug makers to detail youth-specific effects. Food and Drug Administration. Newsline People AIDS Coalit N Y; 1999 Jan; ():34. PubMed ID: 11367188 [TBL] [Abstract][Full Text] [Related]
19. FDA extra-label restriction on drugs. Varney JE J Am Vet Med Assoc; 1983 Dec; 183(12):1372, 1374-5. PubMed ID: 6654717 [No Abstract] [Full Text] [Related]
20. [Halcion (triazolam) in the treatment of insomnia]. Muzychenko AP; Prokudin VN; Bogdan AN Ter Arkh; 1997; 69(1):65-8. PubMed ID: 9163057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]